Clinical trial
CSP #512 - Options in Management With Anti-Retrovirals
NCT00050089 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00050089 |
|---|---|
| Title | CSP #512 - Options in Management With Anti-Retrovirals |
| Official title | CSP #512 - Options in Management With Anti-Retrovirals (OPTIMA), Management of Patients With HIV Infection for Whom First and Second-line Highly Active Anti-Retroviral Therapy Has Failed |
| Acronym | OPTIMA |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Collaborators | Medical Research Council Canadian Institutes of Health Research (CIHR) |
| Status | Completed |
| Study type | Interventional |
| Conditions | AIDS, HIV Infections |
| Intervention type | Drug, Other |
| Interventions | No Antiretroviral Drug-Free Period (No ARDFP) vs ARDFP, Standard ART vs Mega ART |
| Enrollment | 368 |
| Start date | Jan 1, 2001 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Nov 22, 2002 |
| Last update posted | Apr 23, 2015 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: